Sinocelltech Group (688520.SS) Stock Price

Sinocelltech Group Price

SSE·CLOSED
35.01
​
Market closed

Over the last 9 years Sinocelltech Group grew revenue by 36.0% annually, reaching 1.56 B CNY. For Sinocelltech Group, the net margin of -35.5% is up versus -645.0% a few years ago. The consensus 12-month price target for Sinocelltech Group is 56.10 CNY, about 60.2% above where the stock trades today. Of 6 analysts, 5 rate the stock a buy — an overall Buy consensus.

Sinocelltech Group stock price

Access this data via the Eulerpool API

Sinocelltech Group business model & stock analysis

Sinocelltech Group Ltd. engages in the research and development, and manufacture of biopharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 1,868 full-time employees. The company went IPO on 2020-06-22. The firm focuses on monoclonal antibodies, recombinant proteins and vaccine products. Its main products are SCT800, SCT200, SCT-I10A, SCT400, SCT510, SCT1000 and SCT630, among others. The firm is also engaged in asset leasing business and payment collection business.

Frequently asked questions about Sinocelltech Group

Analysts currently set an average price target of 56.10 CNY for the Sinocelltech Group stock (median: 56.10 CNY), implying +60.2 % versus the latest price. The consensus is based on 6 analyst ratings.

6 analysts currently rate the Sinocelltech Group stock: 5 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Sinocelltech Group to generate revenue of 1.65 B CNY and earnings per share of -0.88 CNY.

Converted at the current exchange rate, the Sinocelltech Group share trades at 4.66 EUR (35.01 CNY).

The Sinocelltech Group share (688520.SS) is listed on 1 stock exchanges, including: Shanghai (688520.SS).

The expected revenue of Sinocelltech Group is 1.65 B CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Sinocelltech Group is -405.26 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Sinocelltech Group is currently -39.94. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Sinocelltech Group stock.

The price-to-sales ratio (P/S) of Sinocelltech Group is currently 9.83. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Sinocelltech Group stock.

The Eulerpool Quality Score for Sinocelltech Group is 2/10.

The ISIN of Sinocelltech Group is CNE100003ZL3. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Sinocelltech Group is 688520.SS. The ticker symbol is used to trade Sinocelltech Group shares on the stock exchange.

Fair ValueTerminal
30.11 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
835,199.68 CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CNY
Initial public offering
Jun 22, 2020
ISIN
CNE100003ZL3
Cusip
Y7T97K106
Market capitalization
15.59 B CNYLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-39.94
P/Ee 2027
-79.00
P/Ee 2028
1,167.00
P/Se
9.83
EV/EBIT
—
P/B Ratio
121.55
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-59.77 %
Last updated Oct 10, 2026, 5:12 AM

Sinocelltech Group Peer Group

Sinocelltech Group Ticker

SHH · 688520.SS

Sinocelltech Group FIGI

688520:CH · BBG00Q9DT4T3688520:CG · BBG00Q9DT4V0688520:C1 · BBG01FR9Z1G8